The BalancedInvestor Club

Diagnostics Research Industry Analysis

58 companies analyzed • Returns from -468.7% to +401.6%

Company List (59 Results)

View:
Sort:

Industry Performance

(58/58 companies)
2025-06-18 → 2026-06-16
Weighted Avg
+12.3%
Best
+401.6%
Worst
-468.7%
Returns Distribution
Top 5
1. BDSX+401.6%2. ADVB+178.9%3. BIAF+132.5%4. ISPC+98.7%5. GH+92.3%
Bottom 5
1. NOTVQ-468.7%2. NOTV-409.9%3. WGSWW-205.9%4. PRPH-146.1%5. MDXH-132.9%

BDSX

+401.6%

Biodesix Inc

ADVB

+178.9%

Advanced Biomed Inc. Common Stock

BIAF

+132.5%

bioAffinity Technologies, Inc.

ISPC

+98.7%

iSpecimen Inc

GH

+92.3%

Guardant Health Inc

TWST

+86.2%

Twist Bioscience Corp

PRE

+79.5%

Prenetics Global Ltd

BNR

+78.2%

Burning Rock Biotech Ltd

CHEK

+78.1%

Check Cap Ltd

PRPO

+72.7%

Precipio Inc

EXAS

+69.5%

EXACT Sciences Corporation

VCYT

+64.1%

Veracyte Inc

NEOG

+62.4%

Neogen Corporation

ILMN

+59.9%

Illumina Inc

IMDX

+52.1%

Insight Molecular Diagnostics Inc.

MEDP

+42.2%

Medpace Holdings Inc

NEO

+41.2%

NeoGenomics Inc

PSNL

+39.5%

Personalis Inc

SHC

+38.3%

Sotera Health Co

NDRA

+36.4%

ENDRA Life Sciences Inc

1–20 of 59
Page 1 of 3
Methodology

The Weighted Average return (+12.3%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

53 companies with market cap data included: BDSX, ADVB, BIAF, ISPC, GH, TWST, PRE, BNR, CHEK, PRPO and 43 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer